CARsgen Therapeutics (CRTHF) Stock Price, News & Analysis

Company Overview

CARsgen Therapeutics is a biotechnology company focused on developing cell therapies for cancer. The company specializes in chimeric antigen receptor T-cell (CAR-T) treatments, which genetically modify a patient’s immune cells to recognize and attack cancer cells.

Its research and development programs target both blood cancers and solid tumors. The company’s pipeline has included CT053, an anti-BCMA CAR-T therapy for multiple myeloma, and CT041, an investigational CAR-T therapy directed at Claudin18.2, a protein found on certain gastrointestinal and other solid tumors. CARsgen has also pursued additional programs targeting cancer-associated proteins such as GPC3.

Founded in 2017, CARsgen has conducted research, clinical development and manufacturing activities in China and has maintained a presence in the United States, including operations in Houston. The company’s programs are primarily investigational, and their availability and regulatory status may vary by geography.

Key Stats

• Today's Range: $1.62 to $1.62
• 50-Day Range: $1.62 to $1.92
• 52-Week Range: $1.62 to $2.16
• Volume: N/A
• Average Volume: 2,800 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:CRTHF
• Previous Symbol: OTC:CRTHF
• CIK: N/A
• Web: crestnicholson.com
• Phone: 44.19.32580555
• Fax: N/A
• Employees: 477
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A